Cellectar Biosciences Inc (CLRB)

[Snakers]

Everybody was waiting on the cohort 3 results. That is why I believe the stock jumped to its highest levels since the last dilution. I can take it from the last press release that cohort 3 was good enough to move on to cohort 4, but it makes me question where are the cohort 3 results. I believe that is why the stock has pulled back. Not sure I agree with the timing of the release, but I obviously don't have a seat in their board room.

There are biotechs that are seeing huge jumps in price on worse phase I results. Longs will lose a few battles along the way, but I think we will win the war. I am still buying on the dips and selling smaller blocks on the runs. Looking forward to when that isn't a good strategy anymore and the short get their just deserts (yes, technically it is not desserts).